Evidence map›Paper›PMID 36394014›Full record

ArticleFrontiers in bioengineering and biotechnology2022

Formulation of a novel antibacterial topical treatment based on Magnetite-Buforin-II-silver nanobioconjugates.

Laura N Muñoz, Valentina Jaramillo, Mónica Gantiva-Diaz, Javier Cifuentes, Carolina Muñoz-Camargo, Juan C Cruz, Andrés Fernando González Barrios

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Laura N MuñozGrupo de Diseño de Productos y Procesos (GDPP), Departamento de Ingeniería Química y de Alimentos, Universidad de los Andes, Bogotá, Colombia.
Valentina JaramilloGrupo de investigación en Nanobiomateriales, Ingeniería Celular y Bioimpresión (GINIB), Departamento de Ingeniería Biomédica, Universidad de los Andes, Bogotá, Colombia.
Mónica Gantiva-DiazGrupo de investigación en Nanobiomateriales, Ingeniería Celular y Bioimpresión (GINIB), Departamento de Ingeniería Biomédica, Universidad de los Andes, Bogotá, Colombia.
Javier CifuentesGrupo de investigación en Nanobiomateriales, Ingeniería Celular y Bioimpresión (GINIB), Departamento de Ingeniería Biomédica, Universidad de los Andes, Bogotá, Colombia.
Carolina Muñoz-CamargoGrupo de investigación en Nanobiomateriales, Ingeniería Celular y Bioimpresión (GINIB), Departamento de Ingeniería Biomédica, Universidad de los Andes, Bogotá, Colombia.
Juan C CruzGrupo de investigación en Nanobiomateriales, Ingeniería Celular y Bioimpresión (GINIB), Departamento de Ingeniería Biomédica, Universidad de los Andes, Bogotá, Colombia.
Andrés Fernando González BarriosGrupo de Diseño de Productos y Procesos (GDPP), Departamento de Ingeniería Química y de Alimentos, Universidad de los Andes, Bogotá, Colombia.
Universidad de Los Andes · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Community acquired infections caused by Meticillin-resistant

Indexed as

antibacterial activityantimicrobial peptidebiocompatibilityBUF-IIdirect emulsionsnanobioconjugatesstability

Identifiers

PMID36394014
PMCPMC9649911
OpenAlexW4307707381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.